Let’s have real coffee with βιος-SBSCy at one of the most remarkable venues in Cyprus: the UCY Library!

Dear friends, members of the βιος-SBSCy,

Join us on Thursday 21st March at 17.00 hours in the LRC012 auditorium of the Library at the Univ. of Cyprus new campus (https://library.ucy.ac.cy/)

PRESENTATION BY:

Dr Athos Antoniades CEO and Head of Research at Stremble Ventures LTD

Title: “Scientific leadership in international projects and opportunities to collaborate with a Cyprus-based Biotech company”

Athos will showcase international projects in which his team is involved:

  • Comfortage, a 20m euro project (Horizon) of a consortium of 39 European partners, focusing on dementia and frailty;
  • Cardiocare, a 6m euro project (Horizon), studying cardiotoxicity induced by breast cancer treatments;
  • Myeloma- Risk, an ERC-PoC project were a novel approach to analyzing somatic mutations yields promising results in the prognosis of disease progression; 
  • CyprusGenome.org – A project led by Karaiskakio Foundation and CSHM on the genetic characterization of the Cypriot population; 
  • The Cyprus Intestinal Health Study – A clinical study that identified novel biomarkers for Colon Cancer in the Cypriot population. 

Athos will also present opportunities for research positions that will be becoming available.

Q&A and discussion

Coffee and refreshments will be served!

See you there (and please come on time)!

Follow the signs to the LRC012 auditorium from the entrance of the Library at the University of Cyprus !

Athos Antoniades completed his Ph.D. at the University of Cyprus and his undergraduate studies at SCSU, USA. He started his career at Glaxo Smith Kline, and has worked at the UCY (Computer Science department and the Medical School), the CING and Frederic University. His research focuses on Computational Biology and Bioinformatics. Athos established Stremble Ventures, a research company working in over 20 projects across Europe, USA and Asia. He also works as the National eHealth authority, leading the scientific coordination of Xt-EHR.

Stremble Ventures Ltd is built around a core interdisciplinary team of computer scientists, clinicians, bioinformaticians, statisticians and molecular biologists. It offers advanced analytics, bioinformatics and software engineering expertise for clinical trials, studies and medical research; its mission is to deliver innovative biotechnological and digital solutions in collaboration with an extensive global network of academic and industrial partners.

For non-members-why not join us? You can participate in a vibrant scientific community that you can call home!

Spread the love

Similar Posts

  • THE SBSCy SEMINAR SERIES 2022

      Jeffrey Harvey   Senior scientist at Netherlands Institute of Ecology and Endowed Professor, Faculty of Science, Vrije Universiteit Amsterdam  Thursday 8th December, 2022, 5pm  ‘GREEN BACKLASH: Evaluating the corporate and media assault on science’   Brief CV: 1991: BSc Liverpool University; 1991-1995, PhD, Liverpool University on the nutritional ecology of parasitoids. Post docs: 1995 (Keele University, UK),…

    Spread the love
  • THE SBSCy SEMINAR SERIES 2023

    Dr Menno Schilthuizen Naturalis Biodiversity Center and Leiden University Wednesday 08 February 2023, 18.00 sharp Darwin Comes to Town Our 2023 program continues, this time in collaboration with the Hellenic Evolutionary Society (HEVOS) of Greece, with a lecture by Prof. Dr Menno Schilthuizen An established evolutionary biologist at Naturalis Biodiversity Center and Leiden University(The Netherlands),…

    Spread the love
  • THE SBSCy SEMINAR SERIES 2023

    Martina Foglizzo University of Leeds Thursday 28 September 2023, 17.00 Cyprus time BRCA1-BARD1 bridges across nucleosomes and “inchworms” on chromatin, using multiple interaction modules ABSTRACT Cellular responses to DNA double strand breaks (DSBs) are dependent on a set of nucleosome “signposts” that are written, read and erased by highly specialised multi-protein complexes. The tumour suppressor…

    Spread the love
  • THE SBSCy SEMINAR SERIES 2022

    Ilias Georgakopoulos-Soares Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA 94158, USA -Ilias.GeorgakopoulosSoares@ucsf.edu Thursday 14th April, 2022, 5pm ‘Novel technologies for the detection of human disease’ Detection of disease, including cancer, at the earliest stage is of paramount importance for successful treatment. Even though liquid biopsies are an exciting and highly…

    Spread the love
  • THE SBSCy SEMINAR SERIES 2024

    Ethan L Morgan University of Sussex Thursday 22 February 2024 5 pm Cyprus time Targeting protein ubiquitination to improve the response to chemoradiotherapy in HPV-positive cancer ABSTRACT Human papillomaviruses (HPV) are a major cause of cancer worldwide, and are the primary cause of almost all cervical cancers and a growing number of cancers of the…

    Spread the love
  • THIRD COFFEE WITH SBSCy

    Dear friends, members of the SBSCy, We are back from the Summer break, and we are are ready to continue our series of “Coffee with the SBSCy” with exciting events coming up! We are inviting you to third second ““Coffee with the SBSCy” on Wednesday September 15th, at 17hr Cyprus time, via Zoom. Members will…

    Spread the love